A $64,000 research grant is awarded to Dr. Claire Dubois, PhD, Professor at the Université de Sherbrooke – Faculty of Medicine and Health Sciences (FMSS) and her team for the project titled: "Medical Technology Based on the Chicken Embryo-patient Avatar for Improving Drug Treatment for Glioma Patients." High grade gliomas can spread rapidly through brain tissue which typically leads to very poor prognosis for patients.

The grant supports the innovative Sherbrooke Brain Cancer Avatar Initiative, employing novel CAMavatar technology to test drug responses quickly and without the ethical concerns and high costs associated with traditional models. Dr. Dubois highlights the potential impact of the research: "We believe that our CAMavatar technology will give high-grade glioma patients their best chance at survival by identifying the most effective treatment for each patient. This could dramatically transform the clinical management of gliomas, offering personalized therapies that are tailored to the unique characteristics of each tumor." 

This grant was made possible by the generous contributions of our founding sponsor Scotia Wealth Management, and Brain Cancer Canada corporate and personal donors. 

Press release available at:
https://www.globenewswire.com/en/news-release/2024/05/16/2883435/0/en/Brain-Cancer-Canada-Awards-Grant-for-Innovative-Medical-Avatar-Technology-to-Improve-Treatments-in-High-Grade-Gliomas-like-Glioblastoma.html